Literature DB >> 20682772

Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.

Maurice Perrinjaquet1, Marçal Vilar, Carlos F Ibáñez.   

Abstract

The signaling mechanisms by which neurotrophic receptors regulate neuronal survival and axonal growth are still incompletely understood. In the receptor tyrosine kinase RET, a receptor for GDNF (glial cell line-derived neurotrophic factor), the functions of the majority of tyrosine residues that become phosphorylated are still unknown. Here we have identified the protein-tyrosine phosphatase SHP2 as a novel direct interactor of RET and the first effector known to bind to phosphorylated Tyr(687) in the juxtamembrane region of the receptor. We show that SHP2 is recruited to RET upon ligand binding in a cooperative fashion, such that both interaction with Tyr(687) and association with components of the Tyr(1062) signaling complex are required for stable recruitment of SHP2 to the receptor. SHP2 recruitment contributes to the ability of RET to activate the PI3K/AKT pathway and promote survival and neurite outgrowth in primary neurons. Furthermore, we find that activation of protein kinase A (PKA) by forskolin reduces the recruitment of SHP2 to RET and negatively affects ligand-mediated neurite outgrowth. In agreement with this, mutation of Ser(696), a known PKA phosphorylation site in RET, enhances SHP2 binding to the receptor and eliminates the effect of forskolin on ligand-induced outgrowth. Together, these findings establish SHP2 as a novel positive regulator of the neurotrophic activities of RET and reveal Tyr(687) as a critical platform for integration of RET and PKA signals. We anticipate that several other phosphotyrosines of unknown function in neuronal receptor tyrosine kinases will also support similar regulatory functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682772      PMCID: PMC2951258          DOI: 10.1074/jbc.M110.144923

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5.

Authors:  Fernanda Ledda; Gustavo Paratcha; Carlos F Ibáñez
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

2.  Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells.

Authors:  T Iwase; C G Jung; H Bae; M Zhang; B Soliven
Journal:  J Neurochem       Date:  2005-08-08       Impact factor: 5.372

3.  Structure and chemical inhibition of the RET tyrosine kinase domain.

Authors:  Phillip P Knowles; Judith Murray-Rust; Svend Kjaer; Rizaldy P Scott; Sarah Hanrahan; Massimo Santoro; Carlos F Ibáñez; Neil Q McDonald
Journal:  J Biol Chem       Date:  2006-08-23       Impact factor: 5.157

4.  The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands.

Authors:  Gustavo Paratcha; Fernanda Ledda; Carlos F Ibáñez
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

5.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

Authors:  L F Lin; D H Doherty; J D Lile; S Bektesh; F Collins
Journal:  Science       Date:  1993-05-21       Impact factor: 47.728

6.  Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival.

Authors:  Mario Encinas; Robert J Crowder; Jeffrey Milbrandt; Eugene M Johnson
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

7.  Identification of RET autophosphorylation sites by mass spectrometry.

Authors:  Yoshiyuki Kawamoto; Kozue Takeda; Yusuke Okuno; Yoshinori Yamakawa; Yasutomo Ito; Ryo Taguchi; Masashi Kato; Haruhiko Suzuki; Masahide Takahashi; Izumi Nakashima
Journal:  J Biol Chem       Date:  2004-01-06       Impact factor: 5.157

8.  Targeted mutation of serine 697 in the Ret tyrosine kinase causes migration defect of enteric neural crest cells.

Authors:  Naoya Asai; Toshifumi Fukuda; Zaiqi Wu; Atsushi Enomoto; Vassilis Pachnis; Masahide Takahashi; Frank Costantini
Journal:  Development       Date:  2006-10-18       Impact factor: 6.868

9.  Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation.

Authors:  Ti Cai; Keigo Nishida; Toshio Hirano; Paul A Khavari
Journal:  J Cell Biol       Date:  2002-10-07       Impact factor: 10.539

10.  SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase.

Authors:  H Nicholas Marsh; Catherine I Dubreuil; Celia Quevedo; Anna Lee; Marta Majdan; Gregory S Walsh; Sharon Hausdorff; Farid Arab Said; Olga Zoueva; Maya Kozlowski; Katherine Siminovitch; Benjamin G Neel; Freda D Miller; David R Kaplan
Journal:  J Cell Biol       Date:  2003-12-08       Impact factor: 10.539

View more
  20 in total

1.  Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment.

Authors:  Lloyd A Greene; Oren Levy; Cristina Malagelada
Journal:  Cell Mol Neurobiol       Date:  2011-03-10       Impact factor: 5.046

Review 2.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

3.  Expression and functional analyses of ephrin type-A receptor 2 in mouse spermatogonial stem cells†.

Authors:  Hiroko Morimoto; Mito Kanatsu-Shinohara; Kyle E Orwig; Takashi Shinohara
Journal:  Biol Reprod       Date:  2020-02-12       Impact factor: 4.285

4.  The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines.

Authors:  Alessandra Dicitore; Elisa Stellaria Grassi; Michele Caraglia; Maria Orietta Borghi; Germano Gaudenzi; Leo J Hofland; Luca Persani; Giovanni Vitale
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

Review 5.  Structure and physiology of the RET receptor tyrosine kinase.

Authors:  Carlos F Ibáñez
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

6.  A sympathetic neuron autonomous role for Egr3-mediated gene regulation in dendrite morphogenesis and target tissue innervation.

Authors:  David H Quach; Michelle Oliveira-Fernandes; Katherine A Gruner; Warren G Tourtellotte
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

Review 7.  State-of-the-Art Strategies for Targeting RET-Dependent Cancers.

Authors:  Vivek Subbiah; Dong Yang; Vamsidhar Velcheti; Alexander Drilon; Funda Meric-Bernstam
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

8.  The potential neuroprotection mechanism of GDNF in the 6-OHDA-induced cellular models of Parkinson's Disease.

Authors:  Feng Li; Meng Wang; Shuan Zhu; Li Li; Ye Xiong; Dian-Shuai Gao
Journal:  Cell Mol Neurobiol       Date:  2013-07-12       Impact factor: 5.046

Review 9.  Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.

Authors:  Simona M Wagner; ShuJun Zhu; Adrian C Nicolescu; Lois M Mulligan
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.

Authors:  Bradley D DeNardo; Michael P Holloway; Qinqin Ji; Kevin T Nguyen; Yan Cheng; Marcus B Valentine; Arthur Salomon; Rachel A Altura
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.